Jonas Bengtsson joins Scandinavian Biopharma as VP Business Development and International Sales

Jonas Bengtsson joins Scandinavian Biopharma with more than 20 years of experience from the vaccine-, pharmaceutical- and medtech-industry including, Sales, Marketing, Business Development and Licensing. His strategic business thinking, his track record of delivering results and his experience around the world are key to accompany Scandinavian Biopharma on its growth path.

Jonas started to work in sales with vaccines for GlaxoSmithKline in 1996. He was in 2001 responsible for establishing the GSK vaccine Business Unit in Sweden including travel, paediatric and flu vaccines. In 2006 Jonas joined SBL vaccines/ Crucell as commercial head of the Nordic, North America and Australia.

In 2010 he joined BSN medical with task to start the Nordic subsidiary. In 2014 he was promoted to SVP Wound Care Vascular in Hamburg. This role included leading global marketing, product development and strategic acquisitions within the franchise.

– Scandinavian Biopharma is a very dynamic and fast-growing company. To be part of this professional team will be very exciting and I look forward to add value to the business in the next coming years, says Jonas Bengtsson, who will be responsible for Business Development and International Sales.

– I’m very pleased to welcome Jonas to Scandinavian Biopharma. With his strong track record in the health care industry he will be an important contributor to our continuous growth going forward, says Björn Sjöstrand, CEO Scandinavian Biopharma.

Ämnen

Scandinavian Biopharma

Scandinavian Biopharma is a Swedish research-based biotech company specialist in marketing and sales of vaccines, immunoglobulin’s, biodefense, antidotes and diagnostic tests.

Research and development is mainly focused on development of a new oral traveler’s diarrhea vaccine in collaboration with PATH Vaccine Solutions and University of Gothenburg.

www.scandinavianbiopharma.se

Kontakter

Björn Sjöstrand

Presskontakt VD bjorn@scandinavianbiopharma.se +46 (0)72 712 51 20

Relaterat innehåll

8 Juni 2017 08:01

Scandinavian Biopharma continues to grow - 2016 was another successful year

2016 was another successful year with continued strong growth for Scandinavian Biopharma. For the distribution business, which are conducted through the subsidiary Scandinavian Biopharma Distribution, revenue growth landed at impressive 43%.

Charlotte Flodin, VP Quality Assurance at Scandinavian Biopharma

6 November 2017 11:12

Charlotte Flodin joins Scandinavian Biopharma as VP Quality Assurance

Scandinavian Biopharma continues to expand and strengthen its organization. In August Charlotte Flodin started as VP Quality Assurance. Charlotte has more than 20 years of experience in the pharmaceutical industry and previously worked at Octapharma as Quality Assurance Manager.

25 April 2018 15:05

Scandinavian Biopharma gets support by the County Administrative Board in Stockholm

Scandinavian Biopharma Distribution (SBD) has been granted a business development check by the County Administrative Board in Stockholm. Business Development checks are the County Administrative Board's support for companies that want to take in external skills to develop the company and strengthen its competitiveness. The support for SBD will be used for internationalization of the business.

25 April 2018 15:00

Scandinavian Biopharma Distribution får stöd av Länsstyrelsen i Stockholm

Scandinavian Biopharma Distribution (SBD) har beviljats en affärutvecklingscheck på 250 000 SEK av Länsstyrelsen i Stockholm. Affärsutvecklingscheckar är Länsstyrelsens stöd till företag som vill ta in extern kompetens för att utveckla företag och stärka dess konkurrenskraft. Stödet till SBD skall användas för internationalisering av verksamheten.

22 Maj 2018 16:14

Scandinavian Biopharma is once again looking back on a highly successful business year

We are very proud to report completion of a large Phase I/II child study in Bangladesh, we were awarded 30 MSEK from Horizon 2020 SME and we kick-started a Phase IIB study on travellers to Benin. We have strengthened our organization and continued to grow our distribution business.

Kyoko Misawa, Clinical study manager at Scandinavian Biopharma

1 Juni 2018 11:07

Kyoko Misawa joins Scandinavian Biopharma as Clinical study manager

Scandinavian Biopharma continues to expand and strengthen its organization. In April Kyoko Misawa started as Clinical Study Manager at Scandinavian Biopharma’s research subsidiary ETVAX AB. Kyoko has more than 20 years’ experience from the pharmaceutical and life science industry in both Japan and Sweden within the field of diabetes, antibiotic, inflammation and orphan drugs